A

Alector

D
ALEC
USD
0.405
(7.7364%)
Market Closed
21,963.00
Volume
-1.94
EPS
-
Div Yield
-3.116022
P/E
548,890,789.68
Market Cap
Today
11.4625%
1 Week
14.518%
1 Month
24.503%
6 Months
6.415%
12 Months
-1.913%
Year To Date
-29.323%
All Time
-71.673%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
7.38521E-5
(0.2005%)
USD

Title:
Alector

Sector:
Healthcare
Industry:
Biotechnology
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Do you need help or have a question?
Contact Us